Time Restricted Eating for Obesity
Trial Summary
What is the purpose of this trial?
The purpose of this pilot study is to understand the difference between early and late time-restricted eating on weight and body mass index (BMI), and evaluate the barriers encountered and the effect on quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking insulin, sulfonylurea drugs, or weight loss medications.
What data supports the effectiveness of the treatment Early time-restricted eating and Late time-restricted eating for obesity?
Is time-restricted eating safe for humans?
Research shows that time-restricted eating, where food is consumed within a specific time window each day, is generally safe for adults with obesity. Studies found no significant adverse effects on health markers like blood count or eating patterns, suggesting it can be a safe approach for weight management.12367
How does time-restricted eating differ from other treatments for obesity?
Time-restricted eating (TRE) is unique because it focuses on limiting the hours during which you eat each day, rather than changing what you eat. This approach aligns eating patterns with the body's natural circadian rhythms, potentially enhancing metabolic benefits and weight loss without altering calorie intake or diet composition.24789
Research Team
Bradley Bohn, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for obese adults with a BMI of 25 or higher who are willing to limit their eating to an 8-hour window. It's not suitable for those with cancer, pregnant or breastfeeding women, individuals who regularly skip meals, those on certain diabetes or weight loss medications, and people with a history of eating disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow a time-restricted eating schedule for 12 weeks, either early or late window
Follow-up
Participants are monitored for changes in weight, cholesterol, glucose, and other health markers
Treatment Details
Interventions
- Early time-restricted eating
- Late time-restricted eating
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor